Reed Welch

Managing Director

Reed Welch co-leads the firm’s U.S. practice in the health care technology and technology-enabled services, including provider, payor, and patient-centric solutions. Reed joined Raymond James in 2009 as part of the firm's acquisition of Lane, Berry & Co., where he led health care technology coverage since 2003 – totaling over 17 years of dedicated coverage to the health care technology sector. Prior to Lane Berry, Reed spent about a decade as a generalist investment banker at Donaldson, Lufkin & Jenrette and its successor, Credit Suisse First Boston. Reed’s transaction experience includes sell-side and buy-side acquisition engagements, special committee advisory assignments, as well as public and private financing transactions. Illustrative health care technology clients include AAPC, Navia Benefit Solutions, Solutran, GoodRx, Proteus Digital, Health Catalyst, Wellbeing Software, Crisis Prevention Institute, Phreesia, Quantros, Benefit Resource, Advent Int’l (target: Definitive Healthcare), Rhapsody (target: Corepoint Health), Cambio Healthcare Systems, Jvion, MDLive, Hg Capital (target: Rhapsody), Maxwell Health, Redbrick Health, Office Practicum, ConnectiveRx, Healthcare Bluebook, Provant, Qgenda, Cardinal Health/NaviHealth (target: Curaspan), Connecture, ShapeUp, Benefitter, HealthStream, Press Ganey, The Advisory Board Company, PatientKeeper, voalte, HealthEquity, Qualifacts, bswift, Castlight Health, NexTech, Premier, Benefitfocus, SuccessEHS, Empyrean Benefit Solutions, Surescripts, MedSeek, Greenway Medical, Payflex, Carefx, Medicity, Axolotl, Evolution Benefits and Amicas. Reed holds a Bachelor of Arts in International Business from Ohio Wesleyan University.